TickerFacts.

Compare

Labcorp Holdings Inc. vs Castle Biosciences Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearLabcorp Holdings Inc.
LH		Castle Biosciences Inc
CSTL
Year ended2025-12-312025-12-31
Revenue$13.95B$344.23M
Revenue growth (YoY)+7.2%+3.7%
Gross margin28.8%79.4% (computed)
Operating margin9.9%-12.4%
Net margin6.3%-7.0%
Net income$876.50M-$24.16M
EPS (Diluted)$10.46-$0.83
Operating cash flow$1.64B$64.35M
Free cash flow$1.21B$28.33M
Cash & equivalents$532.30M$116.73M
Total assets$18.39B$578.56M
Total liabilities$9.76B$107.68M
Shareholders' equity$8.62B$470.87M
Return on year-end equity10.2%-5.1%
Shares outstanding82.20M29.69M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearLabcorp Holdings Inc.Castle Biosciences Inc
Latest$13.95B
Ended 2025-12-31		$344.23M
Ended 2025-12-31
1 year earlier$13.01B
Ended 2024-12-31		$332.07M
Ended 2024-12-31
2 years earlier$12.16B
Ended 2023-12-31		$219.79M
Ended 2023-12-31
3 years earlier$11.86B
Ended 2022-12-31		$137.04M
Ended 2022-12-31
4 years earlier$13.14B
Ended 2021-12-31		$94.08M
Ended 2021-12-31